[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Viral N. Shah\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":42},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":27,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":5},"100615079",false,"NCT07287943","To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.","Efficacy and Safety of Medtronic 780G Automated Insulin Delivery System in Adults With Type 1 Diabetes and Gastroparesis","Inclusion criteria\n\n* Age ≥18 years\n* Diagnosis of T1D for at least 12 months with stable insulin regimen for at least 2 months\n* HbA1c ≥8.0%\n* Diagnosis of gastroparesis per National Institute of Health (NIH) definition\n* Willing to use Medtronic 780G system either with Simplera CGM.\n* Ability to provide informed consent before any trial-related activities\n* If randomized to usual care group and on an insulin pump already, should be willing to use pump in manual mode only for the duration of the study\n\nExclusion criteria\n\n* Age \\\u003C18 years\n* Current use of inhaled insulin (Afrezza)\n* Patients with T1D using any glucose lowering medications other than insulin at the time of screening\n* Pregnancy, breast feeding, or wanting to become pregnant\n* Current use (≥ 2 weeks of continuous use) of any steroidal medication, or anticipated long-term steroidal treatment (\\>4 weeks continuously), during the study period\n* History of gastric outlet obstruction or other gastrointestinal structural abnormalities\n* Estimated glomerular filtration rate (eGFR) \\\u003C30 or on dialysis\n* History of SH in the previous 3 months\n* History of two or more episodes DKA requiring hospitalization in the past 12 months\n* Any medical (such as severe cardiovascular disease, malignancy, chronic liver disease) or psychosocial conditions that make a person unfit for the study at the discretion of investigators\n* Use of investigational drugs within 5 half-lives prior to screening\n* Current use of cannabis or history of cannabinoid hyperemesis syndrome","ALL","18 Years",{"count":18,"type":19},34,"ESTIMATED","INTERVENTIONAL",[22],"NA","The goal of this clinical trial is to evaluate the efficacy and safety of Medtronic 780G automated insulin delivery system in adult persons with type 1 diabetes and gastroparesis.",[25,26],"Type 1 Diabetes","Gastroparesis Due to Diabetes Mellitus Type I",[28,29],"type 1 diabetes","gastroparesis","RECRUITING","2026-02-14",{"date":33,"type":34},"2026-02-18","ACTUAL",{"date":36,"type":34},"2026-02-09",{"date":38,"type":19},"2026-12-01",{"name":40,"class":41},"Viral N. Shah","OTHER",""]